Harvard Bioscience (HBIO) EBITDA Margin Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -321.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -658.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -315.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 192.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 563.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -331.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2,844.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 26.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -495.00 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 22,245.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,245.00 |
| Dec 31, 2025 | 14,612.00 |
| Sep 30, 2025 | 949.00 |
| Jun 30, 2025 | 495.00 |
| Mar 31, 2025 | -21,881.00 |
| Dec 31, 2024 | 2,299.00 |
| Sep 30, 2024 | -485.00 |
| Jun 30, 2024 | -1,173.00 |
| Mar 31, 2024 | -1,513.00 |
| Dec 31, 2023 | -2,364.00 |
| Sep 30, 2023 | 1,030.00 |
| Jun 30, 2023 | -1,092.00 |
| Mar 31, 2023 | 2,916.00 |
| Dec 31, 2022 | 1,086.00 |
| Sep 30, 2022 | -1,582.00 |
| Jun 30, 2022 | 1,349.00 |
| Mar 31, 2022 | -2,244.00 |
| Dec 31, 2021 | 190.00 |
| Sep 30, 2021 | -78.00 |
| Jun 30, 2021 | 396.00 |